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Abstract. Preconditioning is complex, strong, evolu-
tionary conserved cellular survival mechanism that is ex-
hibited by different species as well as in different organs.
A focused approach on microarray evaluation of precon-
ditioning will be used to highlight the lack of clarity in
investigating this complex phenomenon, exacerbated by
the absence of a standardised terminology. This paper is
an extensive review of the scientific literature on the in-
vestigation of preconditioning by means of a microarray
approach. It dissects the design of the experiments used
to investigate such phenomenon and classifies the com-
plex factors in investigating preconditioning. It presents
an attention to detail to the lexicon with a suggested
classification and terminology that describes precondi-
tioning that may help stratify and clarify research in
this field.
Keywords: preconditioning, microarray, complex
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1 Introduction
Preconditioning is a complex, evolutionary conserved,
cellular survival phenomenon. The protective effect of
preconditioning is described in different species as well
as in different organs of the same species such as the
heart (Correa-Costa et al., 2012; Jassem et al., 2009;
Jun et al., 2011), the lung (Jun et al., 2011), the kid-
ney (Correa-Costa et al., 2012), the liver (Jassem et
al., 2009), the intestines (Wang et al., 2009), the retina
(Kamphuis et al., 2007), the spinal cord (Carmel et al.,
2004; Kim et al., 2008), the brain (Hirata et al., 2007;
Kawahara et al., 2004) and skeletal muscle (Harralson et
al., 2005; Moses et al., 2005). It is also possible to trans-
fer this protective effect from a preconditioned rat heart
to that of a naive rat heart using the coronary effluent
(Serejo et al., 2007). The same effect has been shown in
rabbits (Dickson et al., 1999; Leung et al., 2014).
This phenomenon falls under the wider term of
hormesis. This term was first described by Southam
et al. (1943) and recently revived by Calabrese (2004).
Hormesis refers to a pattern of cellular responses to
stressors whereby a beneficial effect results from expos-
ure to low doses of agents or intensities of environmental
factors that are otherwise toxic or lethal when given at
higher concentration or intensities (Krenz et al., 2013).
Murry et al. (1986) were among the first to report a type
of preconditioning known as ‘ischemic preconditioning’
and referred to it as a ‘rapid, adaptive response to a
brief ischaemic insult, which slowed the rate of cell death
during a subsequent prolonged period of ischemia’. In
a dog heart model, they were able to prove that this
phenomenon could reduce the infarct size by 75%. Four
years later Kitagawa et al. described ischaemic precon-
ditioning in the brain of gerbils (Kitagawa et al., 1990).
Understanding one of the strongest cellular defence
mechanisms is challenging for many reasons. A focused
approach on microarray evaluation will be used to high-
light the lack of clarity in investigating this complex phe-
nomenon, exacerbated by the absence of a standardised
terminology. The following is a review of the scientific
literature investigating preconditioning by means of a
microarray approach and presents an attention to detail
to the lexicon with a suggested terminology describing
preconditioning that may help stratify and clarify re-
search in this field.
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Figure 1: Showing: A (red) – Challenge. (Single or separated
by two reperfusion episodes) B (blue) – Early Protection from
Insult C (green) – Late protection from Insult
2 Preconditioning, gene expression and
microarrays
Preconditioning is triggered by a stimulus, which will
be forthwith referred as the ‘challenge’. This challenge
will protect the cell from a more potent ensuing event
from now on referred to as the ‘insult’. The protect-
ive effect is bi-temporal and is exhibited in local as well
as in remote tissue (figure 1). Thus, preconditioning
can be described as having four phases of protection.
The first phase of protection occurs within minutes of
the insult A (Red in figure 1), lasts 2 to 3 hours (B)
(Blue in figure 1) and is commonly referred to as clas-
sic preconditioning (Bolli, 2000). The second phase of
protection comes on at about 24 hours after the chal-
lenge and lasts up to 72 hours (C) (Green in figure 1)
and is commonly known as the second window of protec-
tion (SWOP) (X. M. Yang et al., 1996). The above two
phases describe local protection. The protective effect
is transmitted to remote organs giving rise to two other
phases commonly known as early and late remote pre-
conditioning (Leung et al., 2014; Przyklenk et al., 1993).
Towards the beginning of the 1990’s the main focus of in-
vestigation was on the classic phase of preconditioning.
Thornton et al. (1990) reinforced this drive by show-
ing that the inhibition of protein synthesis did not alter
myocardial protection afforded by preconditioning. The
receptor-based response seen in classic preconditioning
is a vital rapid response to the stressor (challenge) and
can be considered a ‘knee jerk or reflex’ response that
is not dependent on gene transcription. The delayed re-
sponse which was described in 1995 by Yellon et al. is
however a complex gene expression response, possibly
an ‘intelligent’ response with the capability of anticip-
ating potential ensuing threats (insults). Two main ge-
netic approaches have been used in studying this aspect
of preconditioning; candidate gene approach and gen-
ome wide analysis. The former is built around a hypo-
thesis about the role of particular pathways such as in-
flammation, followed by a search for changes in specific
gene expression levels related to inflammation by means
of tools such as the polymerase chain reaction (PCR).
These are in vitro models that are very useful because
biochemical molecules can be used to alter the pathway
under investigation and study its effect and relevance.
A top to bottom approach using genome wide analysis
interrogating the expression of thousands of genes in a
single experiment such as in microarray analysis or next
generation sequencing (NGS) as compared to the latter
reductionist approach is an important tool in uncovering
key molecular events in the cell’s response to precon-
ditioning. Limitations of these gene expression stud-
ies include, restricted time points, limited and biased
transcripts represented on the array, the nature of the
sample analysed, as well as an absence of clearly defined
models (Kawahara et al., 2004).
3 Complex factors in preconditioning
Several factors that make preconditioning a complex
process to study can be identified. These can be broadly
subdivided into intrinsic and extrinsic factors. Intrinsic
factors relate to the nature of the phenomenon and
include; a wide spectrum of challenges, a bi-temporal
nature and a spatial element. The extrinsic factors re-
late to the diverse experimental designs adopted by re-
searchers, terminology and semantics used in describing
the phenomenon and the overwhelming information gen-
erated by recent technology.
3.1 Intrinsic Factors
The intrinsic factors are inherent to the phenomenon
and thus are not amenable to alteration however when
identified they can be approached systematically fa-
cilitating a holistic approach in researching the phe-
nomenon.
3.1.1 Wide spectrum of challenges
The first intrinsic factor is the wide spectrum of chal-
lenges that can induce preconditioning leading to the
activation of diverse complex networks culminating to a
common effect of enhanced cellular tolerance. These
challenges include; hypoxia (Bernaudin et al., 2002),
hyperthermia (Du et al., 2010), hypothermia (Nishio
et al., 2000), epileptic fits (Sasahira et al., 1995) and
drugs such as acetylsalicylic acid (Riepe et al., 1997).
These are not simply challenges exclusive to the labor-
atory but have also been studied in the natural setting
in humans. This is thought to occur in patients with
ischaemic heart disease who exhibits recurrent anginal
chest pain (Costa et al., 2005; Wall et al., 1994) or in pa-
tients with cerebrovascular disease who exhibit transient
ischemic attacks (Moncayo et al., 2000). The different
challenges studied in different species under different ex-
perimental conditions looking at different phases of pre-
conditioning leads to a multiplier effect on the number
of complex variables.
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3.1.2 Bi-temporal nature
The second intrinsic complex factor is the bi-temporal
nature creating three scenarios for investigation the
third being the processes happening between the first
and second instance. Each scenario is a complex event
to study in its own merit. The preconditioning chal-
lenge invokes an early response with a very rapid mani-
festation of cellular protection that lasts a few hours
and a late response or second wave becoming active at
24 hours from the initial challenge and lasting 72 to
96 hours (figure 1). The first wave is dependent on
preformed molecules and activation of receptors such
as adenosine A1/A3 (Murphy et al., 2008; Tsukamoto
et al., 2005), opioid receptor activation (Schultz et al.,
1995) and to a lesser degree bradykinin B2 (Wall et
al., 1994). These molecules in turn activate down-
stream signalling cascades the earliest being protein
kinase C (PKC). Downstream targets of PKC activation
include 5’-nucleotidase, glycogen synthase kinase-3B
(GSK-3B), mitochondrial permeability transition pore
(mPTP), ATP-sensitive potassium channels in plasma
membranes and mitochondria, proteins involved in ap-
optosis (Bax/Bad and Bcl-2), and adenosine A2b recept-
ors (Costa et al., 2005; Hausenloy et al., 2003; Murphy
et al., 2008; Tsukamoto et al., 2005; X. Yang et al.,
2011). This does not exclude the possibility of an early
genomic response but this is overshadowed by studies
looking at the biochemical response. This is in contrast
to the exponential increase in the literature regarding
the extensive genetic response in the SWOP. A highlight
of this response is the very important up-regulation of
an intrinsic pro-survival genetic program that has been
shown to attenuate apoptosis (Stein et al., 2007).
Intuitively the bi-temporal nature of the phenomenon
drives research into these two time points potentially un-
dermining inquiry into the interim period that possibly
involves cellular memory. It is very plausible that the
second wave involves the activation of a cellular memory
mechanism allowing the cell to mount the response 24
hours after the initial preconditioning stimulus. This
hypothesis is supported by evidence of cellular memory
from studies of a similar phenomenon described in plants
known as ‘priming’ (Pastor et al., 2013).
3.1.3 Spatial element
The third intrinsic factor is the spatial element. The
protective effects are noted both locally at the site of
preconditioning as well as in remote organs involving
complex processes of cell signalling (Guo et al., 2019).
Thus distant organs are somehow receiving the precon-
ditioning trigger allowing them to respond effectively to
the challenge, another mechanism that is still not fully
understood (Billah et al., 2018). The remote organ pro-
tection effect is manifested for both temporal events that
is the classic and SWOP. This remote effect introduces
three scenarios with their own complex factors. The
first is the local mechanism by which a challenged organ
creates a signal that conditioning has happened. The
second scenario is the transmission of this signal that
is thought to involve both neural and humoral factors
(Lim et al., 2010; Shimizu et al., 2009) and the third is
the interpretation of this signal by distant organs and
the mounting of a protective response.
3.2 Extrinsic factors
Studies of preconditioning using microarray techniques
were chosen as the main criterion in order to simplify
and focus analysis on a specific manageable scenario.
Twenty-eight studies from PubMed satisfied the cri-
terion of microarray and preconditioning and are shown
in table 1. The extrinsic factors will be explored further
by using the 28 studies referred to in table 1.
3.2.1 Classification and terminology
The first extrinsic factor is process classification and ter-
minology. Using gene expression as the scenario it is
clear from the literature that it is challenging to the
unfamiliar reader to understand what phase of the pre-
conditioning phenomenon is under investigation. This
is confounded by the fact that different authors use dif-
ferent terminology to describe the same phases of pre-
conditioning. In order to clarify and simplify this is-
sue of preconditioning phases it is suggested that they
are classified into four different phases based on tem-
poral and spatial factors and that a standard termino-
logy with an abbreviation system is adopted. The tem-
poral response can be subdivided into two parts, early
and late. The early response, referred to as ‘classical’,
‘immediate’, ‘acute’ or ‘early phase’ preconditioning is
very rapid and confers tolerance lasting between 2 to 3
hours (figure 1). This is followed by an interim period
where tolerance is not exhibited. The late phase is re-
ferred to as the second window of protection ‘SWOP’,
‘delayed’ preconditioning and ‘late phase’ precondition-
ing sets in at around 24 hours after the initial challenge
and lasts up to 72 hours. Both the early and the late
responses have a spatial component that is local and
remote, transmitting the signal to distant cells and or-
gans. The remote component is known as remote pre-
conditioning. Remote preconditioning is expressed in
both temporal aspects and thus the distant cells exhibit
both early remote preconditioning as well as late remote
preconditioning. Table 2 illustrates current terms used
in describing preconditioning and a proposed classifica-
tion and nomenclature shown in italics that integrates
the different aspects of preconditioning.
The proposed terms and abbreviations would thus be
local early preconditioning (LEPC), local late precondi-
tioning (LLPC), remote early preconditioning (REPC),
10.7423/XJENZA.2020.1.01 www.xjenza.org
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Spatial – Local Spatial – Remote
Temporal – Early
(2 to 3 hours)
Local early PC (LEPC) Remote early PC (REPC)
Classical PC Remote PC
Immediate PC Remote ischemic PC
Acute PC
Early phase PC
Temporal – Late
(24 to 72 hours)
Local late PC (LLPC) Remote late PC (RLPC)
Second window of protection Remote delayed PC
Delayed PC
Late Phase PC
Table 2: Current and proposed terms describing preconditioning (PC). The terms in italics are alternative terms that are found
in the literature.
System Species Type ofchallenge
Challenge
protocol
Challenge -
insult interval
Type of
insult PC phase 
Genes, Fold
Change &
Platform Setting
Experimental
Design
First author,
Journal & Year
Brain
Cerebral
cortex
Mus
musculus
8-10  weeks
male
C57BL/6J
MCAO 
Single 15-minute
episode of
MCAO
3 days 60 minutesMCAO
Second
phase/
SWOP 
7500 genes 
2.2 fold 
Affymetrix
MG_U74AV1 
- Challenge at 24 
hours                  
- Insult at 24 hours 
- Insult altered by 
challenge 3 days 
before 
Stenzel-Poore,
Lancet, 2003 
Hippocampus
(CA1 cells)
Rattus
norvegicus
      
male 
Wistar
SPF
BCAO Single 2-minuteepisode of BCAO 3 days
6 minutes
BCAO
Second
phase/
SWOP
7000 genes 
2 fold  
Affymetrix
RG_U34A 
- Challenge at 1, 3, 
12, 24 & 48 hours   
- Insult at 1, 3, 12, 
24 & 48 hours       
- Insult altered by 
challenge 3 days 
before  
Kawahara, J
Cereb Blood Flow
Metab, 2004 
Frontoparieta
l cortex
Rattus
norvegicus                
adult male 
SHR
kwaa
MCAO
Single 10-minute
episode of
MCAO
3 days 60 minutesMCAO
Second
phase/
SWOP
1263 genes 
2 fold 
Affymetrix
RG_U34
- Challenge at 3, 6, 
12, 24 & 72 hours  
- Insult at 6 hours 
- Insult altered by 
challenge 3 days 
before  
Dhodda, J
Neurochem,
2004   
Cerebral
cortex
Mus
musculus
adult male
Swiss(not
starved)
Hypoxia
by 8%
oxygen in
nitrogen
Single 1 or 6
hour episode of
hypoxia 
12,18 & 24 hours PermanentMCAO
Second
phase/
SWOP
6000 genes
1.5 fold 
Affymetrix
MG_U17A
- 2 challenges at 12,
18, 24 & 72 hours
- Insult at 6 hours 
- Insult altered by 
challenge 12, 18 & 
24 hours before
Tang, Neurobiol
Dis, 2006 
Hippocampus
(CA3 sector)
Mus
musculus 
C57BL/6
Seizure by
intra-
peritoneal
kainic acid 
Single episode of
seizures 1 day
Status
epilepticus
by intra-
amygdala
kainic acid
Second
phase/
SWOP
39000 genes
 
1.8 fold 
Affymetrix 430 2.0 
- Challenge at 24 
hours
- NA
- Insult altered by 
challenge 1 day 
Hatazaki,
Neuroscience,
2007 
Table 1: Showing a description of preconditioning microarray experiments according to system, species, type of challenge, challenge
protocol, challenge-insult interval, type of insult, preconditioning phase, genes, fold change and microarray platform setting, gene
expression profile analysis and fist author, journal, year and reference number. (SHR – spontaneously hypertensive; MCAO –
middle cerebral artery occlusion; BCAO bilateral cerebral artery occlusion ; HBO – hyperbaric oxygen; CpG – cytosine-guanine;
LPS - lipopolysaccharide; OGD – oxygen-glucose deprivation; CAO – coronary artery occlusion; IPC – ischemic preconditioning;
APC – anesthetic preconditioning; MAC – minimum alveolar concentration: SMAO – ; BP – blood pressure; NA – Not Available;
PC – Preconditioning and SWOP – second window of protection (table continues overleaf, 1/6)
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chip before
Cerebral
cortex
Rattus
norvegicus 
neonatal
Sprague
Dawley
Hypoxia
by 8%
oxygen in
nitrogen
(36°C)
Single 3 hour
episode of
hypoxia
2, 8 & 24 hours Killed NA
30000 genes
1.2 fold 
Affymetrix
Rat230_2 
- Challenge at 2, 8 
& 24 hours
- NA
- NA
Gustavsson, 
Pediatr Res, 2007 
Hippocampus
(CA1 cells)
Rattus
norvegicus
neonatal
male
 
Wistar
HBO
(3.5
atmosphere
absolute)
Single 1 hour
episode of HBO
each day for 5
consecutive days
6, 12, 24 & 72
hours
8 minutes
forebrain
ischemia
First/ classic
& second
phase/
SWOP
20500 genes
Fold change NA 
AgilentDNA Oligo
- NA
- NA
- Insult altered by 
challenge 6, 12, 24 
& 72 hours before
Hirata, Brain Res,
2007   
Forebrain
(global
ischemia)
Rattus
norvegicus
male
Wistar
(fasted)
BCAO Single 3 minuteepisode of BCAO 3 days
6 minutes
BCAO
Second
phase/
SWOP
23060 genes
1.25 fold
Affymetrix
Rat230_2
- NA
- Insult at 1, 4 & 24
hours                   
- Insult altered by 
challenge 3 days 
before 
Feng, Brain Res,
2007 
Hippocampus
(CA1 & CA3
sectors)
Rattus
norvegicus
adult male
Sprague
Dawley
Seizures by
intraperito
neal Kainic
acid
Single 20 minute
episode of
seizures on day 1
& day 2
1 day
Status
epilepticus
by intra-
peritoneal
kainate or
pilocarpine
Second
phase/
SWOP
10179 genes
1.25 fold
 
Affymetrix
RAE230A 
- Challenge at 24 
hours 
- Insult at 1 & 3 
days
- Insult altered by 
challenge 1 day 
before
Borges, Neurobiol
Dis, 2007   
Frontal
cortex
Mus
musculus
8-10 weeks
C57BL/6
CpG
oligodeoxy
nucleotide
intraperito
neal
injection
Single episode of
CpG 3 days
MCAO
(time not
specified) 
Second
phase/
SWOP
NA
1.5 fold
 Affymetrix 
MOE430 2.0
- NA
- Insult at 24 hours 
-Insult altered by 
challenge 3 days 
before
Marsh,Stroke,
2009     
Frontal
cortex
Mus
musculus
LPS intrap
eritoneal
injection
Single episode of
LPS 3 days
45 minutes
MCAO
Second
phase/
SWOP
NA
- Challenge at 3, 24 
& 72 hours
- Insult at 3 & 24 
Marsh, J
Neurosci, 2009 
Table 1: Continuation of table 1 (2/6)
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C57BL/6 
1.5 fold 
Affymetrix MOE430
2.0
hours                  
- Insult altered by 
challenge 3 days 
before
Hippocampus
Rattusnorv
egicus
adult
 
Sprague
Dawley
OGD Single 5 minuteepisode of OGD NA
10 minutes
OGD NA
NA
1.3 fold
Affymetrix
Rat230_2
- Challenge at 3, 6 
& 12 hours
- NA
- NA            
Benardete, Brain
Res, 2009 
Cerebral
cortex
Mus
musculus
adult male
 C57BL/6J 
MCAO
Single 15 minute
episode of
MCAO
1 day 60 minutesMCAO
Second
phase/
SWOP
NA
- Challenge at 24 
hours
- Insult at 24 hours 
- Insult altered by 
challenge 1day 
before
Lusardi, J Cereb
Blood Flow
Metab, 2010    
Cortical
neurons (in
vitro)
Rattus
norvegicus
18 day
embryonic
Wistar 
OGD 
Single 15 minute
episode of OGD
alternating with
15 minute
reperfusion for 3
cyles
1 day 120 minutesOGD
Second
phase/
SWOP
NA
1.5 fold 
Agilent G413 60mer
4x44 
- Challenge at 3 
hours
- NA
- Insult altered by 
challenge 1 day 
before
Prasad, J Mol
Neurosci, 2012 
Heart
Heart 
(in vivo) 
Oryctolagu
s cuniculus
New
Zealand
white
rabbit
Circumflex
branch
CAO
Single 5 minute
episode of CAO
alternating with
5 minute
reperfusion for 2
cycles
NA NA NA
18376 genes
5fold
NA
- Challenge at 5 
hours
- NA
- NA
Simkhovich, Heart
Dis, 2002 
Heart
(Langendorf
isolated &
perfused)
Rattus
norvegicus
male
Wistar
Langendor
ff heart no
flow
ischemia
Single 5 minute
episode of
ischemiaalternati
ng with 5
minutereperfusio
n for 3 cycles
NA
30 minutes
no flow
myocardial
ischemia 
NA
3200 genes
 NA    NA
- NA
- Insult at 2 hours
-NA
Onody, FEBS
Lett, 2003 
Table 1: Continuation of table 1 (3/6)
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Heart
(Langendorf
isolated &
perfused) 
Rattus
norvegicus
male
Wistar
IPC by no
flow
ischemia &
APC by
isoflurance
(1.5 MAC)
IPC - Single 5
minute episode of
ischemia
alternating with
5 minute
reperfusion for 3
cycles APC –
Single 110
minute episode of
isoflurance
NA NA NA
8800 genes
2 fold 
Affymetrix
RG_U34A 
- Challenge at 110 
minutes
- NA
- NA
Sergeev,
Anesthesiology,
2004  
Heart 
(in vivo)
Mus
musculus
10-12
weeks
C57BL/6  
Hind limb
ischemia
by
occlusion
of femoral
artery
Single 4 minute
episode of
occlusion
alternating with
4 minute
reperfusion for 6
cycles
15 minutes & 24
hours Killed
NA
NA
1.5 fold
AffymetrixMG_430
A
- Challenge at 15 
minutes & 24 hours
- NA
- NA 
Konstantinov, J
Thorac
Cardiovasc Surg,
2005 
Heart 
(in vivo)
Mus
musculus/
Rattus
norvegicus
male 
ICR/
Wistar
Hypoxia
by a high-
altitude
chamber
(380 Torr)
Single 15 hour
episode of
hypoxia for 2, 4
& 8 weeks
NA NA NA
6144 genes
2 fold
NA
– Challenge at 2, 4 
& 8 weeks     - NA
- NA
Chen, Shock, 2005 
Myocardial,
renal,
intestinal, &
lung
Mus
musculus
adult male
Swiss
Webster
SMAO
 Single 2-minute
episode of SMAO
alternating with
2- minute
reperfusion  for 2
cycles
1 day Killed NA
1176 genes
1.7 fold
NA
- Challenge at 24 
hours
- NA
- NA
Huda, Heart Lung
Circ, 2005    
Heart 
(in vivo)
Rattus
norvegicus 
male
Wistar
NA
Single 5 minute
episode of
ischemia
alternating with
10 minute
reperfusion for 2
10 minutes
40 minutes
ischemia
(type not
specified) 
First/ classic
phase
NA
NA
- NA
- Insult at 30 
minutes               
- Insult altered by 
challenge 10 
minutes before
Canatan, Cell
Biochem Funct,
2008  
Table 1: Continuation of table 1 (4/6)
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cycles CodeLink bioarrays
Blood
Leukocytes
Homo
sapiens 
adult male
and female
Forearm
ischemia
by BP cuff
inflation (2
00mmHg)
Single 5 minute
episode of
ischemia
alternating with
5 minute
reperfusionfor 3
cycles 
NA NA NA
NA
1.5 fold
Affymetrix
HG_U133A 
- Challenge at 24 
hours
- NA
- NA
Konstantinov,
Physiol Genomics,
2004 
Retina
Retina
Rattus
norvegicus
Male
Wistar
Eye
anterior
chamber
induced
pressure by
a 1.7m
head
Single 5 minute
episode of
ischemia
alternating with
24 hour
reperfusion
1 day
60 minutes
of anterior
chamber
raised
pressure
Second
phase/
SWOP
NA
NA
AgilentG4130A
- NA
- Insult at 1, 2, 6 & 
12 hours
– Insult altered by 
challenge 1 day 
before
Kamphuis, Mol
Vis, 2007 
Lung
Lung Rattusnorvegicus
Cessation
of
ventilation
and
perfusion
by
clamping
of
pulmonary
vessels
Single 5 minute
episode of
ischemia
alternating with5
minute
reperfusion for 3
cycles
NA
2 hours of
cold
ischemia
NA
22226 genes
2 fold 
Illumina
Rat Ref-12
expression beadchip 
- NA
- Insult at 1, 3, 6 & 
24 hours
- NA
Jun, J Surg Res,
2011 
Intestines
Small
intestine
(transplant)
Rattus
norvegicus
adult male
Sprague
Dawley
SMAO
Single 10 minute
episode of
ischemia
alternating with
10 minute
reperfusion
10 minutes Transplantation 
First/ classic
phase
4096 genes 
NA
NA
- NA
- Insult at 1 hour    
- Insult altered by 
challenge 10 
minutes before
Wang, J Surg
Res, 2009 
Table 1: Continuation of table 1 (5/6)
10.7423/XJENZA.2020.1.01 www.xjenza.org
10 Complex factors in preconditioning a microarray gene
Kidney
Kidney
(in vivo) 
Mus
musculus
male
C57BL/6
No flow
ischemia
by
clamping
of both
renal
pedicles
Single 15 minute
episode of
ischemia 
1 week
45 minute
renal
pedicle cross
clamp
Second
phase/
SWOP
NA
2/3 fold
Agilent 
4x44 K whole
genome microarray
- NA
- Insult at 6 hours 
- Insult altered by 
challenge 1 week 
before
Correa-Costa,
PLoS One, 2012 
Liver
Liver
 (in vivo) 
Homo
sapiens
Pringle’s
manoeuvre
occluding
porta
hepatis by
a
tourniquet
Single 10 minute
episode of porta
hepatis clamping
30 minutes Transplantation
First/ classic
phase 
NA
NA
Affymetrix
HG_U133A
- NA
- Insult at 2 hours 
- Insult altered by 
challenge 30 
minutes before
Jassem, Liver
Transpl, 2009 
Liver
 (in vivo)
Homo
sapiens
Pringle’s
manoeuvre
occluding
porta
hepatis by
a
tourniquet
Single 10 minute
episode of porta
hepatis clamping
NA Transplantation
First/ classic
phase
NA? 
NA
NA
NA
- NA
- Insult at 90 
minutes               
- NA
Raza, Liver
Transpl, 2010       
Table 1: Continuation of table 1 (6/6)
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and remote late preconditioning (RLPC). Another ter-
minological issue is the terms used when referring to
the stimuli used to trigger preconditioning; the main
stressor that is modified by preconditioning. Since many
stimuli can trigger preconditioning and there are differ-
ent methods for achieving this, it would be helpful if
the stimuli used to trigger preconditioning are always
referred to as the ‘challenge’ and the main stressor that
is modified by preconditioning is referred to as the ‘in-
sult’.
3.2.2 Diverse investigational design
The second extrinsic complexity factor refers to the di-
verse investigational design adopted by researchers. In
such a complex process, structure of design using stand-
ard protocols, classification and nomenclature is of ut-
most importance. Different preconditioning challenges
elicit different biochemical and genetic response path-
ways limiting the significance of comparisons between
studies. The different challenges in microarray stud-
ies utilized to induce preconditioning include hypoxia
(MCAO, BCAO, hypoxia chamber, CAO, NFI, HLI,
SMA, FAI, EAIP, CPV and OPH) (Bernaudin et al.,
2002), hyperbaric oxygen (HBO), high altitude (Os-
trowski et al., 2008), oxygen glucose deprivation (OGD)
(Himori et al., 1991; Ito et al., 2000), hyperthermia (Du
et al., 2010), hypothermia (Nishio et al., 2000), lipo-
polysaccharides (LPS) and oligodeoxynucleotide (Huang
et al., 2013; Yu et al., 1999). Other challenges used
in preconditioning experiments but not in these mi-
croarray studies are epileptic seizures (Belosjorow et al.,
1999; Rosenzweig et al., 2007; Sasahira et al., 1995),
cortical spreading depression (Kobayashi et al., 1995),
chemical preconditioning with compounds such as 3-
nitropropionic acid (3-NP) (Riepe et al., 1996), antibi-
otics such as erythromycin and kanamycin (Huber et al.,
1999), acetylsalicylic acid (Riepe et al., 1997), N-methyl-
D-aspartate (NMDA) (Himori et al., 1991), doxorubi-
cin (Ito et al., 2000), 2-deoxyglucose (Yu et al., 1999)
and sulfur dioxide (Huang et al., 2013). Microarrays in-
terrogate a huge number of genes that may vary from
one thousand to thirty-five thousand genes generating
a huge amount of data. A comparison of different mi-
croarrays would be a good approach to understand the
genomic response in preconditioning but the diversity
of challenges used in this field is an important limiting
factor.
Another important factor in design apart from the
type of challenge is the duration and frequency of the
challenge. The duration of the hypoxic challenge used
by different investigators varies from 5 to 15 minutes
of bilateral cerebral artery occlusion (BCAO). Another
issue in structure is defining clearly what phase of the
preconditioning is under investigation; local or remote,
classic or SWOP. Gene expression investigations can fo-
cus on the effect of challenge on gene expression in local
or remote tissue when compared to controls as well as
the altering effect of the challenge on the insult expres-
sion profile. Out of the 7 studies on the heart, 6 looked
at the effect of the challenge on gene expression whilst
only one investigation looked at the effect of challenge
in altering gene expression profile during the insult. In
the latter study the time period between the challenge
and the insult is not specified leaving unanswered the
issue of whether classic or second window of protection
was under study. Therefore, when studying the effect of
the challenge on the insult gene expression profile, the
timing between the challenge and the insult needs to
be clearly defined. There is also large variability in the
insult methods used. In the neuro studies the middle
cerebral artery occlusion (MCAO) occlusion challenge
varied from 45 to 60 minutes to permanent. Given the
limited number of microarray studies in preconditioning
it would be useful to focus on specific organs. Most of
the work has been carried out on the brain (14 studies)
and the heart (7 studies), undoubtedly due to the clin-
ical importance of myocardial infarction and stroke, the
commonest causes of death in western countries. Single
studies investigated blood, retina, lung, small intestines,
kidney and liver. Species variability included 14 studies
in rats, 10 in mice, 2 in humans and 1 in the rabbit.
Only two studies looked at the gene expression changes
secondary to preconditioning at a remote site.
3.2.3 Overwhelming information
The final complex factor is the inevitable information
overload generated by the advent of an ever-increasing
array of powerful data generating investigational tools
available for the researcher and which are constantly
evolving. Tools such as microarrays have generated tera-
bytes of data and as can be seen from table 1 the types
of arrays used and the number of genes investigated has
varied over time. This complicates the issue of data in-
tegration as well as the comparison of data with earlier
investigations. Another new technology, which is bound
to generate an even greater load of information, is next
generation sequencing. New discoveries such as epigen-
etics can become a potential contributor to informa-
tion overload. In fact, research into the epigenetics of
preconditioning has started to be published from 2013
(Thompson et al., 2013).
4 Conclusion
Complex systems in biology such as preconditioning
need a concerted effort in order to be deciphered. Sci-
entific approaches, such as systems biology, an inter-
disciplinary field of study that focuses on complex in-
teractions within biological systems, using a holistic ap-
proach as opposed to the more traditional reduction-
ism are essential. The study of preconditioning needs
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a ‘systems thinking’ approach based on a set of habits
or practices facilitating the research in this field. This
review proposes a basic practice, that of a standard-
ized nomenclature and classification. The terms defined
included ‘phases’ of preconditioning, ‘challenge’ and ‘in-
sult’. Table 2 is a proposal of terms used to describe the
four phases of preconditioning. A clearer description
of the investigation should also be taken into considera-
tion. A definition from the outset of the model, whether
in vitro or in vivo, the species studied, the type of chal-
lenge and the challenge protocol whether it is single or
multiple episodes, form part of an essential approach
in understanding preconditioning. When it comes to
microarrays other essential issues include the design of
an experiment that looks into the genetic expression re-
sponse to the challenge, the genetic expression response
to the insult and how the challenge alters the genetic
response of the insult. Finally, time points such as the
interval between the challenge and the insult and the
interval between the challenge or insult and the gene
expression investigation should be clearly defined from
the outset.
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